Need to keep on prime of the science and politics driving biotech right this moment? Enroll to get our biotech publication in your inbox.
Morning! Right now, we hear Vinay Prasad defend his contentious vaccine place at a closed-door investor convention, see a famend Harvard computational biologist wrestle financially after Trump funding cuts gutted his funding, and extra.
At a closed-door investor convention in New York, FDA vaccines chief Vinay Prasad railed towards “deceptive media narratives” as backlash mounts over his push to require bigger, longer research for up to date vaccines, STAT’s Damian Garde studies. His proposal has drawn a rare public rebuke from 12 former FDA commissioners.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.